Controversy in thyroid disease

Journal of the Royal College of Physicians of London

Volumn 34, Issue 4, 2000, Pages 374-380

  Weetman, Anthony P ^a,b  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THYROXINE;

GRAVES DISEASE; HISTORY OF MEDICINE; HYPOTHYROIDISM; RASH; SHORT SURVEY;

ANTITHYROID AGENTS; CLINICAL TRIALS; DECISION MAKING; GOITER; GRAVES DISEASE; HUMANS; HYPOTHYROIDISM; IODINE RADIOISOTOPES; PROGNOSIS;

EID: 0033899526     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (44)

1. Glinoer D, Hesch D, Lagasse R, Laurberg P. The management of hyperthyroidism due to Graves' disease in Europe in 1986. Results of an international survey. Acta Endocrinol 1987;185:9-37.
2. Solomon B, Glinoer D, Lagasse R, Wartofsky L. Current trends in the management of Graves' disease. J Clin Endocrinol Metab 1990;70: 1518-24.
3. Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. Brit Med J 1996;313: 539-44.
4. Davies TF, Roti E, Braverman LE, DeGroot LJ. Thyroid controversy -stimulating antibodies. J Clin Endocrinol Metab 1998;83:3777-85.
5. Weetman AP, Pickerill AP, Watson P, Chatterjee VK, Edwards OM. Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapse. Quart J Med 1994;87:337-41.
6. Hashizume K, Ichikawa K, Sakurai A, Suzuki S, et al. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med 1991;324: 947-53.
7. McIver B, Rae P, Beckett G, Wilkinson E, et al. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. N Engl J Med 1996;334:220-4.
8. Rittmaster RS, Abbott EC, Douglas R, Givner ML, et al. Effect of methimazole, with or without L-thyroxine, on remission rates in Graves' disease. J Clin Endocrinol Metab 1998;83:814-8.
9. Anonymous. Drug-induced agranulocytosis. Drug Ther Bulletin 1997;35:49-52.
10. Toft AD, Weetman AP. Screening for agranulocytosis in patients treated with antithyroid drugs. Clin Endocrinol 1998;49:271.
11. Fukata S, Kuma K, Sugawara M. Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Thyroid 1999;9: 29-31.
12. Hall P, Lundell G, Holm L-E. Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinol 1993;128:230-4.
13. Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J, Boyle P. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 1998;338:712-8.
14. Ron E, Doody MM, Becker DV, Brill AB, et al. Cancer mortality following treatment for adult hyperthyroidism. JAMA 1998;280: 347-55.
15. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J, Boyle P. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 1999; 353:2111-5.
16. Rivkees SA, Sklar C, Freemark M. The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998;83:3767-76.
17. Hedley AJ, Lazarus JH, McGhee SM, Jones RB, et al. Treatment of hyperthyroidism by radioactive iodine. Summary of a UK national survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes. J R Coll Physicians Lond 1992;26: 348-51.
18. The Radioiodine Audit Subcommittee of the Royal College of Physicians Committee on Diabetes and Endocrinology, The Research Unit of the Royal College of Physicians. The use of radioiodine in the management of hyperthyroidism. London: Royal College of Physicians of London, 1995:1-26.
19. Jarløv AE, Hegedüs L, Kristensen Lø, Nygaard B, Hansen JM. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while? Clin Endocrinol 1995;43:325-9.
20. Kendall-Taylor P, Keir MJ, Ross WM. Ablative radioiodine therapy for hyperthyroidism: long term follow-up study. Brit Med J 1984;289: 361-3.
21. Imseis RE, Vanmiddlesworth L, Massie JD, Bush AJ, Vanmiddlesworth NR. Pre-treatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 1998;83:685-7.
22. Sabri O, Zimny M, Schulz G, Schreckenberger M, et al. Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication. J Clin Endocrinol Metab 1999;84:1229-33.
23. Bogazzi F, Bartalena L, Brogioni S, Scarcello G, et al. Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism. J Clin Endocrinol Metab 1999;84: 499-503.
24. DeGroot LJ, Gorman CA, Pinchera A, Bartalena L, et al. Radiation and Graves' ophthalmopathy. J Clin Endocrinol Metab 1995;80:339-49.
25. Bartalena L, Marcocci C, Bogazzi F, Manetti L, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998;338:73-8.
26. Bartalena L, Marcocci C, Tanda ML, Manetti L, et al. Cigarette smoking and treatment outcomes in Graves' ophthalmopathy. Ann Int Med 1998;129:632-5.
27. Weetman AP, Wiersinga WM. Current management of thyroid-associated ophthalmopathy in Europe: results of an international survey. Clin Endocrinol 1998;49:21-8.
28. Weetman AP. The role of surgery in primary hyperthyroidism. J Roy Soc Med 1998;91:7-11.
29. Ljunggren J-G, Törring O, Wallin G, Taube A, et al. Quality of life aspects and costs in treatment of Graves' hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomised study. Thyroid 1998;8:653-9.
30. Schwartz AE, Clark OH, Ituarte P, Gerfo PL. Thyroid surgery - the choice. J Clin Endocrinol Metab 1998;83:1097-105.
31. Wheeler MH. Total thyroidectomy for benign thyroid disease. Lancet 1998;351:1525-6.
32. Laurberg P, Nygaard B, Glinoer D, Grussendorf M, Orgiazzi J. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 1998;139:584-6.
33. Momotani N, Noh JY, Ishikawa N, Ito K. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab 1997;82:3633-6.
34. Mandel SJ, Brent GA, Larsen PR. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid 1994; 4:129-33.
35. Weetman AP. Hypothyroidism: screening and subclinical disease. Brit Med J 1997;314:1175-8.
36. Arbelle JE, Porath A. Practice guidelines for the detection and management of thyroid dysfunction. A comparative review of the recommendations. Clin Endocrinol 1999;51:11-18.
37. Haddow JE, Palomaki GE, Allan WC, Williams JR, et al. Maternal thyroid deficiency during pregnancy and subsequent neurophysiological development of the child. N Engl J Med 1999;341:549-5.
38. Toft AD. Thyroid hormone replacement - one hormone or two? N Engl J Med 1999;340:469-70.
39. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange Jr AJ. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999;340:424-29.
40. Gharib H, Mazzaferri EL. Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Int Med 1998;128:386-94.
41. Papini E, Petrucci L, Guglielmi R, Panunzi C, et al. Long-term changes in nodular goiter: a 5-year prospective randomised trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 1998;83:780-3.
42. 131I treatment of nodular non-toxic goitre. Eur J Endocrinol 1996;134:15-20.
43. Le Moli R, Wesche MFT, Tiel-van Buul MMC, Wiersinga WM. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre. Clin Endocrinol 1999;50:783-9.
44. Bonnema SJ, Bertelsen H, Mortensen J, Andersen PB, et al. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab 1999;84: 3636-41.